How is the Exelixis Inc today?

The Exelixis Inc today is trading in the green, up by 7.43% at 43.37.

How has Exelixis Inc performed historically?

The Exelixis Inc is currently trading up 7.43% on an intraday basis in the past week the index rose 4.28%. The index has been up 17.34% in the past quarter and rose 95.36% in the past year. You can view this in the overview section.

What is Exelixis Inc Annual Revenue?

Exelixis Inc Annual Revenue rose 18.49%, in the last year to $2,168.7 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Exelixis Inc Annual Net Profit?

Exelixis Inc Annual Net Profit rose 150.89% in the last year to $521.27 M. Its sector's average net profit growth for the last fiscal year was -14.05%.

What is Exelixis Inc Price to Earning Ratio?

Exelixis Inc Price to Earning Ratio is 18.38, higher than its sector PE ratio of 4.57.

What is Exelixis Inc Stock Price?

Exelixis Inc Stock Price rose 95.36% and outperformed its sector by 29.64% in the past year.

What is Exelixis Inc Quarterly Revenue?

Exelixis Inc Quarterly Revenue rose 30.62% YoY to $555.45 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Exelixis Inc Quarterly Net profit?

Exelixis Inc Quarterly Net profit rose 327.73% YoY to $159.62 M. Its sector's average net profit growth YoY for the quarter was -236.06%.

What is Exelixis Inc Debt to Equity Ratio?

Exelixis Inc Debt to Equity Ratio of 0.09 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Exelixis Inc Return on Equity(ROE)?

Exelixis Inc Return on Equity(ROE) for the last financial year was 23.13%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

What is Exelixis Inc Mutual Fund Holding?

Exelixis Inc Mutual Fund Holding increased by 0.32% in the last quarter to 64.28.

What is Exelixis Inc Promoter Share Holding?

Exelixis Inc Promoter Share Holding decreased by 0.1% in the most recent quarter to 2.23%.

What is Exelixis Inc Institutional Holding?

Exelixis Inc Institutional Holding remained the same in the last quarter at 94.9%.

Exelixis Inc XNAS: EXEL

Exelixis Inc Live Share Price Today, Share Analysis and Chart

Name: Exelixis Inc: Is Infosys Ltd. worth buying?
Item: Exelixis Inc
Rating: 2.991083375
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

about

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and f...

43.37 3.00 (7.43%)

New 52W High today

9.4M

XNAS Volume

High volume+gain today

XNAS 23 Jun, 2025 5:30 PM (EDT)

Postive Trial

Exelixis rises on Monday as its cancer drug combo shows positive results in phase-3 trial See details

High Financial Strength

66.7 / 100

Mid Valuation

43.8 / 100

Technically Moderately Bullish

62.1 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM

1Yr Price target downside is -3%

19 analysts

Exelixis Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Exelixis Inc Live Share Price Today, Share Analysis and Chart

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and f...

New 52W High today

High volume+gain today

SWOT Analysis

Exelixis Inc Live Price Chart

Exelixis Inc FAQ

How is Exelixis Inc today?

Exelixis Inc today is trading in the green, and is up by 7.43% at 43.37.

How has Exelixis Inc performed historically?

Exelixis Inc is currently trading up 7.43% on an intraday basis. In the past week the stock rose 4.28%. stock has been up 17.34% in the past quarter and rose 95.36% in the past year. You can view this in the overview section.